Trial
NCT01374568
Changes in Bone Turnover With Increased Incretin Hormone Exposure
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Alabama at Birmingham
Collaborators
—
Condition
Type 2 Diabetes Mellitus
Intervention
sitagliptin
Why stopped
Study closed by sponsor. Funding ended.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-07-24